Vaccine Skepticism Spreads to Pets; Generics for ADHD Approved; Malaria in Maryland

— Health news and commentary from around the Web gathered by MedPage Today staff

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

Some dog owners questioned pet vaccines like rabies, survey data showed. (Vaccine)

The FDA approved multiple generics of lisdexamfetamine dimesylate to treat attention-deficit/hyperactivity disorder (ADHD) in children 6 years and older and adults, as well as binge-eating disorder in adults.

The Biden administration announced the first 10 drugs up for Medicare price negotiations.

Some individuals said semaglutide (Ozempic,Wegovy) curbed their craving for alcohol. (NPR)

In northern Mexico, an epidemic of Rocky Mountain spotted fever, a tick-borne disease, led to more than 2,000 cases and hundreds of deaths in recent years. (Washington Post)

China will drop its requirement for a negative COVID-19 test from international travelers starting Wednesday. (The Hill)

A case of locally-acquired malaria in Maryland involved a different species from previous cases in Florida and Texas, the CDC said.

Michigan Gov. Gretchen Whitmer (D) will call on state lawmakers to pass legislation aimed at protecting key elements of the Affordable Care Act. (Associated Press)

Pfizer announced plans to restart manufacturing later this year at the North Carolina factory damaged by a tornado in July. (Fierce Pharma)

Astronauts on NASA's SpaceX Crew-7 mission began conducting biomedical research on the International Space Station as part of a 6-month-long, 200-experiment medical research effort. (Fierce Biotech)

Europe will continue to have a shortage of diabetes drugs through September, the European Medicines Agency said. (Reuters)

A whole genome test saved the life of a child; could widespread use could help millions more? (AP)

Elton John returned home Monday after a brief hospital stay following a fall. (People)

The FDA expanded the indication for luspatercept (Reblozyl) to treat anemia in adults with low- to intermediate-risk myelodysplastic syndromes who might require regular blood transfusions, Bristol Myers Squibb said.

Samuel "Joe" Wurzelbacher, known as "Joe the Plumber" during the 2008 presidential campaign, died Sunday at age 49 from pancreatic cancer. (The Hill)

  • author['full_name']

    Michael DePeau-Wilson is a reporter on MedPage Today’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news. Follow